Quantum Brilliance joins consortium developing quantum-enabled brain-on-chip platform
Partners including Chromos Labs, Tessara Therapeutics, Axol Biosciences, and University of Melbourne integrate diamond-based quantum sensing with human neural tissues for neurological drug discovery. Funded by Australian Government.